Harry J. Leonhardt

General Counsel, Chief Compliance Officer & Corporate Secretary at Poseida Therapeutics, Inc.

Harry J. Leonhardt

Harry J. Leonhardt

General Counsel, Chief Compliance Officer & Corporate Secretary at Poseida Therapeutics, Inc.

Overview
Career Highlights

Poseida Therapeutics, Inc.
Halozyme Therapeutics, Inc.
Senomyx Inc.

RelSci Relationships

1684

Number of Boards

2

Birthday

1957

Age

64

Relationships
RelSci Relationships are individuals Harry J. Leonhardt likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Business Officer at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Founder at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Chief Human Resources Officer at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Crinetics Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founder at The Honor Foundation

Relationship likelihood: Strong

Chair at The Executive Leadership Foundation

Relationship likelihood: Strong

Co-Founder at Longitude Capital Management Co. LLC

Relationship likelihood: Strong

Vice President, Corporate Affairs at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Vice President, Business Development at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at GenomeDx Biosciences, Inc.

Relationship likelihood: Strong

Paths to Harry J. Leonhardt
Potential Connections via
Relationship Science
You
Harry J. Leonhardt
General Counsel, Chief Compliance Officer & Corporate Secretary at Poseida Therapeutics, Inc.
Education
Undergraduate Degree

University of the Sciences, are building on a life sciences legacy started almost two centuries ago as Philadelphia College of Pharmacy. From treating, researching and studying diseases and cures on a molecular level to the medicines that improve the lives of people worldwide, USciences is about moving life forward. The University has launched the careers of many innovative and pioneering individuals in the field of healthcare. The University is accredited by the Commission on Higher Education of the Middle States Association of Colleges and Schools.

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

Career History
General Counsel, Chief Compliance Officer & Corporate Secretary
2020 - Current

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.

Senior Vice President, General Counsel & Chief Compliance Officer
2015 - 2020

Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. Our research targets the extracellular matrix, an area outside the cell that provides structural support in tissues and orchestrates many important biological activities, including cell migration, signaling and survival. Over many years, we have developed unique scientific expertise that allows us to pursue this target-rich environment for the development of future therapies. The company's research focuses primarily on human enzymes that alter the extracellular matrix. Our lead enzyme, the recombinant human hyaluronidase (rHuPH20), temporarily degrades hyaluronan, a matrix component in the skin, and facilitates the dispersion and absorption of drugs and fluids. We are also developing novel enzymes that may target other matrix structures for therapeutic benefit. Our ENHANZE™ Technology is the platform for the delivery of proprietary small and large molecules. We apply our research to develop products in partnership with other companies as well as for our own proprietary pipeline in therapeutic areas with significant unmet medical need, such as diabetes, oncology and dermatology. We market Hylenex® recombinant (hyaluronidase human injection) and have partnerships with Roche, Pfizer, Baxter, ViroPharma and Intrexon.

Secretary, Senior Vice President-Legal & Compliance
2007 - 2015

Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA.

Boards & Committees
Director
Prior

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

Transactions
Details Hidden

Halozyme Therapeutics, Inc. issued USD Common Stock

Details Hidden

Amylin Pharmaceuticals, Inc. issued USD Common Stock

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Harry J. Leonhardt. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Harry J. Leonhardt's profile does not indicate a business or promotional relationship of any kind between RelSci and Harry J. Leonhardt.